Inhibin alpha Antibody (PO12/8) [Janelia Fluor® 635]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-61936JF635
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Immunohistochemistry
Label
Janelia Fluor 635
Antibody Source
Monoclonal Mouse IgG2A Clone # PO12/8
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Inhibin alpha Antibody (PO12/8) [Janelia Fluor® 635]
Immunogen
Synthetic peptide corresponding to epitope region aa73-96 of the alphaC region subunit of Inhibin alpha
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for Inhibin alpha Antibody (PO12/8) [Janelia Fluor® 635]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Inhibin A
Alternate Names
INHA, Inhibin A
Gene Symbol
INHA
Additional Inhibin A Products
Product Documents for Inhibin alpha Antibody (PO12/8) [Janelia Fluor® 635]
Product Specific Notices for Inhibin alpha Antibody (PO12/8) [Janelia Fluor® 635]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...